Movatterモバイル変換


[0]ホーム

URL:


Jump to content
WikipediaThe Free Encyclopedia
Search

Oxymetholone

From Wikipedia, the free encyclopedia
Androgen and anabolic steroid
"Androyd" redirects here; not to be confused withAndroid.
Pharmaceutical compound
Oxymetholone
Clinical data
Trade namesAnadrol, Anapolon, others
Other namesCI-406; NSC-26198; 2-Hydroxymethylene-17α-methyl-4,5α-dihydrotestosterone; 2-Hydroxymethylene-17α-methyl-DHT; 2-Hydroxymethylene-17α-methyl-5α-androstan-17β-ol-3-one
AHFS/Drugs.comConsumer Drug Information
Pregnancy
category
  • X
Dependence
liability
Moderate[1]
Addiction
liability
Moderate[1]
Routes of
administration
By mouth
Drug classAndrogen;Anabolic steroid
ATC code
Legal status
Legal status
Pharmacokinetic data
BioavailabilityWell-absorbed[3]
MetabolismLiver[3][4]
Eliminationhalf-lifeUnknown[4]
ExcretionUrine[3][4]
Identifiers
  • (2Z,5S,8R,9S,10S,13S,14S,17S)-17-hydroxy-2-(hydroxymethylidene)-10,13,17-trimethyl-1,4,5,6,7,8,9,11,12,14,15,16-dodecahydrocyclopenta[a]phenanthren-3-one
CAS Number
PubChemCID
DrugBank
ChemSpider
UNII
KEGG
ChEBI
ChEMBL
CompTox Dashboard(EPA)
ECHA InfoCard100.006.454Edit this at Wikidata
Chemical and physical data
FormulaC21H32O3
Molar mass332.484 g·mol−1
3D model (JSmol)
  • O=C4/C(=C\O)C[C@]1([C@@H](CC[C@@H]2[C@@H]1CC[C@]3([C@H]2CC[C@@]3(O)C)C)C4)C
  • InChI=1S/C21H32O3/c1-19-11-13(12-22)18(23)10-14(19)4-5-15-16(19)6-8-20(2)17(15)7-9-21(20,3)24/h12,14-17,22,24H,4-11H2,1-3H3/b13-12-/t14-,15+,16-,17-,19-,20-,21-/m0/s1 checkY
  • Key:ICMWWNHDUZJFDW-DHODBPELSA-N checkY
 ☒NcheckY (what is this?)  (verify)

Oxymetholone, sold under the brand namesAnadrol andAnapolon among others, is anandrogen andanabolic steroid (AAS) medication which is used primarily in the treatment ofanemia.[5][6] It is also used to treatosteoporosis,HIV/AIDSwasting syndrome, and to promoteweight gain[7] andmuscle growth in certain situations.[5] It is takenby mouth.[5][6]

Side effects of oxymetholone include increasedsexual desire as well assymptoms ofmasculinization likeacne,increased hair growth, andvoice changes.[5] It can also causeliver damage.[5][6] The drug is asynthetic androgen and anabolic steroid and hence is anagonist of theandrogen receptor (AR), thebiological target of androgens liketestosterone anddihydrotestosterone (DHT).[5][8] It has stronganabolic effects and weakandrogenic effects.[5]

Oxymetholone was first prescribed in 1959 and was introduced for medical use but was discontinued in 1961 due its high lipid toxicity.[5][9][10][11] It is used mostly in theUnited States.[5][12] In addition to its medical use, oxymetholone is used toimprove physique and performance.[5] The drug is acontrolled substance in many countries and so non-medical use is generally illicit.[5]

Medical uses

[edit]

The primary clinical applications of oxymetholone include treatment ofanemia andosteoporosis, as well as stimulatingmuscle growth in malnourished or underdeveloped patients.[5] However, in theUnited States, the only remainingFDATooltip Food and Drug Administration-approved indication is the treatment ofanemia.[5][13]

Following the introduction of oxymetholone,nonsteroidal drugs such asepoetin alfa were developed and shown to be more effective as a treatment foranemia andosteoporosis without theside effects of oxymetholone.[5] The drug remained available despite this and eventually found a new use in treatingHIV/AIDSwasting syndrome.[5]

Presented most commonly as a 50 mgtablet, oxymetholone has been said to be one of the "strongest" and "most powerful" AAS available for medical use.[5][14] Similarly, there is a risk ofside effects.[15][16] Oxymetholone is highly effective in promoting extensive gains in body mass, mostly by greatly improving protein synthesis.[5] For this reason, it is often used bybodybuilders andathletes.[5]

Non-medical uses

[edit]

Oxymetholone is used forphysique- and performance-enhancing purposes bycompetitiveathletes,bodybuilders, andpowerlifters.[5]

Side effects

[edit]
See also:Anabolic steroid § Adverse effects

The commonside effects of oxymetholone includedepression,lethargy,headache,swelling, fast and excessiveweight gain,priapism, changes in skin color, urination problems,nausea,vomiting,stomach pain (if taken on an empty stomach),loss of appetite,jaundice,breast swelling in men, feeling restless or excited,insomnia, anddiarrhea.[15] In women, side effects also includeacne, changes inmenstrual periods,voice deepening,hair growth on the chin or chest,pattern hair loss,enlarged clitoris, and changes inlibido.[5][15] Because of its 17α-alkylated structure, oxymetholone ishepatotoxic.[5] Long term use of the drug can cause a variety of serious ailments, includinghepatitis,liver cancer, andcirrhosis; therefore periodicliver function tests are recommended for those taking oxymetholone.[16]

Pharmacology

[edit]

Pharmacodynamics

[edit]
Androgenic vs. anabolic activity ratio
of androgens/anabolic steroids
MedicationRatioa
Testosterone~1:1
Androstanolone (DHT)~1:1
Methyltestosterone~1:1
Methandriol~1:1
Fluoxymesterone1:1–1:15
Metandienone1:1–1:8
Drostanolone1:3–1:4
Metenolone1:2–1:3
Oxymetholone1:2–1:9
Oxandrolone1:13–1:3
Stanozolol1:1–1:3
Nandrolone1:3–1:16
Ethylestrenol1:2–1:19
Norethandrolone1:1–1:2
Notes: In rodents.Footnotes:a = Ratio of androgenic to anabolic activity.Sources: See template.

Like other AAS, oxymetholone is anagonist of theandrogen receptor (AR).[5] It is not a substrate for5α-reductase (as it is already 5α-reduced) and is a poor substrate for3α-hydroxysteroid dehydrogenase (3α-HSD), and therefore shows a high ratio ofanabolic toandrogenic activity.[5]

As a DHT derivative, oxymetholone is not asubstrate foraromatase and hence cannot be aromatized intoestrogenicmetabolites.[5] However, uniquely among DHT derivatives, oxymetholone is nonetheless associated with relatively high estrogenicity, and is known to have the potential to produce estrogenic side effects such asgynecomastia (rarely) andwater retention.[5][17][18][19] It has been suggested that this may be due to direct binding to and activation of theestrogen receptor by oxymetholone.[5] Oxymetholone does not possess any significantprogestogenic activity.[5]

Pharmacokinetics

[edit]

There is limited information available on thepharmacokinetics of oxymetholone.[6] It appears to bewell-absorbed withoral administration.[6] Oxymetholone has very lowaffinity for human serumsex hormone-binding globulin (SHBG), less than 5% of that of testosterone and less than 1% of that of DHT.[3] The drug ismetabolized in theliver byoxidation at the C2 position,reduction at the C3 position,hydroxylation at the C17 position, andconjugation.[6][4] The C2 hydroxymethylene group of oxymetholone can becleaved to formmestanolone (17α-methyl-DHT), which may contribute to the effects of oxymetholone.[5] Theelimination half-life of oxymetholone is unknown.[4] Oxymetholone and itsmetabolites areeliminated in theurine.[3][4]

Chemistry

[edit]
See also:List of androgens/anabolic steroids

Oxymetholone, also known as 2-hydroxymethylene-17α-methyl-4,5α-dihydrotestosterone (2-hydroxymethylene-17α-methyl-DHT) or as 2-hydroxymethylene-17α-methyl-5α-androstan-17β-ol-3-one, is asyntheticandrostanesteroid and a17α-alkylatedderivative of DHT.[20][21][5]

History

[edit]

Oxymetholone was first described in a 1959 paper by scientists fromSyntex.[5][9] It was introduced for medical use bySyntex andImperial Chemical Industries in theUnited Kingdom under the brand name Anapolon by 1961.[10][11] Oxymetholone was also introduced under the brand names Adroyd (Parke-Davis) by 1961 and Anadrol (Syntex) by 1962.[22][23][24] The drug was marketed in theUnited States in the early 1960s.[5]

Society and culture

[edit]

Generic names

[edit]

Oxymetholone is thegeneric name of the drug and itsINNTooltip International Nonproprietary Name,USANTooltip United States Adopted Name,USPTooltip United States Pharmacopeia,BANTooltip British Approved Name, andJANTooltip Japanese Accepted Name, whileoxymétholone is itsDCFTooltip Dénomination Commune Française.[20][21][25][12]

Brand names

[edit]

Oxymetholone has been marketed under a variety of brand names including Anadrol, Anadroyd, Anapolon, Anasterona, Anasteronal, Anasterone, Androlic, Androyd, Hemogenin, Nastenon, Oxitoland, Oxitosona, Oxyanabolic, Oxybolone, Protanabol, Roboral, Synasterobe, Synasteron, and Zenalosyn.[20][21][12][5][26]

Availability

[edit]

United States

[edit]
See also:List of androgens/anabolic steroids available in the United States

Oxymetholone is one of the few AAS that remains available for medical use in theUnited States.[27] The others (as of August 2023) aretestosterone,testosterone cypionate,testosterone enanthate,testosterone undecanoate,methyltestosterone,fluoxymesterone, andnandrolone[27]

Other countries

[edit]

The availability of oxymetholone is fairly limited and seems to be scattered into isolated markets inEurope,Asia, andNorth andSouth America.[5] It is known to be available inTurkey,Greece,Moldova,Iran,Thailand,Brazil, andParaguay.[5][12] At least historically, it has also been available inCanada, theUnited Kingdom,Belgium, theNetherlands,Spain,Poland, TheUAE,Israel,Hong Kong, andIndia.[21]

Legal status

[edit]

Oxymetholone, along with other AAS, is aschedule IIIcontrolled substance in theUnited States under theControlled Substances Act.[28]

References

[edit]
  1. ^ab"Anabolic steroid misuse".nhs.uk. 2022-11-04. Retrieved2024-07-12.
  2. ^Anvisa (2023-03-31)."RDC Nº 784 - Listas de Substâncias Entorpecentes, Psicotrópicas, Precursoras e Outras sob Controle Especial" [Collegiate Board Resolution No. 784 - Lists of Narcotic, Psychotropic, Precursor, and Other Substances under Special Control] (in Brazilian Portuguese).Diário Oficial da União (published 2023-04-04).Archived from the original on 2023-08-03. Retrieved2023-08-15.
  3. ^abcdeSaartok T, Dahlberg E, Gustafsson JA (June 1984). "Relative binding affinity of anabolic-androgenic steroids: comparison of the binding to the androgen receptors in skeletal muscle and in prostate, as well as to sex hormone-binding globulin".Endocrinology.114 (6):2100–6.doi:10.1210/endo-114-6-2100.PMID 6539197.
  4. ^abcdefHochadel M (1 April 2015).Mosby's Drug Reference for Health Professions. Elsevier Health Sciences. pp. 1221–.ISBN 978-0-323-31103-8.
  5. ^abcdefghijklmnopqrstuvwxyzaaabacadaeafagahWilliam Llewellyn (2011).Anabolics. Molecular Nutrition Llc. pp. 323–334.ISBN 978-0-9828280-1-4.
  6. ^abcdefPavlatos AM, Fultz O, Monberg MJ, Vootkur A (June 2001). "Review of oxymetholone: a 17alpha-alkylated anabolic-androgenic steroid".Clinical Therapeutics.23 (6):789–801, discussion 771.doi:10.1016/s0149-2918(01)80070-9.PMID 11440282.
  7. ^"Oxymetholone Powder Uses".aea.ltd. Retrieved2022-12-17.
  8. ^Kicman AT (June 2008)."Pharmacology of anabolic steroids".British Journal of Pharmacology.154 (3):502–21.doi:10.1038/bjp.2008.165.PMC 2439524.PMID 18500378.
  9. ^abZderic JA, Carpio H, Ringold HJ (January 1959). "Steroids. CVI. Synthesis of 7β-Methyl Hormone Analogs".Journal of the American Chemical Society.81 (2):432–436.Bibcode:1959JAChS..81..432Z.doi:10.1021/ja01511a041.
  10. ^ab"Advertisements".Proceedings of the Royal Society of Medicine.54 (3): XLI. 1961.PMC 1870224.
  11. ^ab"Advertisements".British Medical Journal.1 (5224). 1961.PMC 1953122.
  12. ^abcd"Oxymetholone".
  13. ^"Oxymetholone".AdisInsight. Springer Nature Switzerland AG.
  14. ^"Anadrol-50"(PDF). Meda Pharmaceuticals. December 2006. Archived fromthe original(PDF) on 11 June 2014. Retrieved8 January 2012.
  15. ^abc"Oxymetholone Side Effects". drugs.com.
  16. ^ab"Anadrol Official FDA Information, Side Effects and Uses". drugs.com.
  17. ^Hengge UR, Stocks K, Wiehler H, Faulkner S, Esser S, Lorenz C, et al. (March 2003)."Double-blind, randomized, placebo-controlled phase III trial of oxymetholone for the treatment of HIV wasting".AIDS.17 (5):699–710.doi:10.1097/00002030-200303280-00008.PMID 12646793.S2CID 29998317.
  18. ^Cortesgallegos V, Castaneda G, Alonso R, Perezpasten E, Reyeslugo V, Barron C, Mondragon L, Villalpando S (January 1982). "Spontaneous and Oxymetholone-Induced Gynecomastia".Journal of Andrology.3 (1). C/O Allen Press, Inc Po Box 368, Lawrence, Ks 66044: Amer Soc Andrology, Inc.: 33.
  19. ^Villalpando S, Mondragon L, Barron C, Reyeslugo U, Perezpasten E, Alonso R, Castaneda G, Gallegos V (January 1982). "5-Alpha Reductase Blockade May Be Responsible for Spontaneous and Oxymetholone-Induced Gynecomastia".Archivos de Investigacion Medica.13 (2). Social Apdo Postal 73-032, Mexico Df 03020, Mexico: Inst Mexicano Seguro.: s13.
  20. ^abcElks J (14 November 2014).The Dictionary of Drugs: Chemical Data: Chemical Data, Structures and Bibliographies. Springer. pp. 924–.ISBN 978-1-4757-2085-3.
  21. ^abcdIndex Nominum 2000: International Drug Directory. Taylor & Francis. January 2000. pp. 779–.ISBN 978-3-88763-075-1.
  22. ^Locum R (1961)."Latest Pharmaceutical Preparations"(PDF).The Central African Journal of Medicine.7 (11):443–444.
  23. ^Clark GM (August 1962). "New drugs in rheumatic disease".Arthritis and Rheumatism.5 (4):415–8.doi:10.1002/art.1780050411.PMID 13879693.
  24. ^Matusow PD (1962)."If - Then; C.A.M.S.I.; In the future"(PDF).Dalhousie Medical Journal.15 (1).
  25. ^Morton IK, Hall JM (6 December 2012).Concise Dictionary of Pharmacological Agents: Properties and Synonyms. Springer Science & Business Media. pp. 212–.ISBN 978-94-011-4439-1.
  26. ^Kochakian CD (6 December 2012).Anabolic-Androgenic Steroids. Springer Science & Business Media. pp. 632–.ISBN 978-3-642-66353-6.
  27. ^ab"Drugs@FDA: FDA Approved Drug Products". United States Food and Drug Administration. Retrieved17 December 2016.
  28. ^Karch SB (21 December 2006).Drug Abuse Handbook, Second Edition. CRC Press. pp. 30–.ISBN 978-1-4200-0346-8.

Further reading

[edit]
  • Pavlatos AM, Fultz O, Monberg MJ, Vootkur A (June 2001). "Review of oxymetholone: a 17alpha-alkylated anabolic-androgenic steroid".Clinical Therapeutics.23 (6):789–801, discussion 771.doi:10.1016/s0149-2918(01)80070-9.PMID 11440282.
Androgens
(incl.AASTooltip anabolic–androgenic steroid)
ARTooltip Androgen receptoragonists
Progonadotropins
Antiandrogens
ARTooltip Androgen receptorantagonists
Steroidogenesis
inhibitors
5α-Reductase
Others
Antigonadotropins
Others
ARTooltip Androgen receptor
Agonists
SARMsTooltip Selective androgen receptor modulator
Antagonists
GPRC6A
Agonists
ERTooltip Estrogen receptor
Agonists
Mixed
(SERMsTooltip Selective estrogen receptor modulators)
Antagonists
GPERTooltip G protein-coupled estrogen receptor
Agonists
Antagonists
Unknown
Retrieved from "https://en.wikipedia.org/w/index.php?title=Oxymetholone&oldid=1306554222"
Categories:
Hidden categories:

[8]ページ先頭

©2009-2025 Movatter.jp